Ozelle Demonstrates AI-Powered Diagnostic Workflows at WHX Labs Dubai 2026
Posted on 11 Feb 2026
At WHX Labs Dubai 2026, Ozelle is exhibiting its advanced diagnostic workflow solution under the theme “AI × CBM: The Next Generation of Complete Blood Morphology.” The system is designed to support decision-ready laboratory workflows by integrating high-resolution morphology imaging, AI-assisted analysis, and scenario-specific diagnostic panels.
Central to the on-site demonstrations is the Intelligent AI Workbench (Open Dx), a unified diagnostic workspace embedded within the analyzer. It converts raw laboratory results into structured, interactive insights, guiding clinicians through actionable information.

Key features include risk stratification, conversational AI report interpretation, critical alerts, and follow-up trend analysis. By integrating test ordering, result review, and AI-assisted interpretation into a single, intuitive workflow, the workbench supports confident, efficient decisions without adding operational burden or extensive training.
Live demonstrations at the exhibition highlight the system’s versatility across multiple clinical scenarios, including infection profiling with combined CBC, CRP, and SAA testing in a single fully automated run without manual reagent switching. The platform also supports everyday disease management through flexible, customizable panels for diabetes, cardiac, and thyroid monitoring, enabling repeatable, high-frequency testing without added workflow complexity.
In addition, AI-powered morphology analysis for malaria risk screening detects red blood cell patterns associated with Plasmodium, delivering high-, medium-, and low-risk indications to support early screening and follow-up in endemic regions. Together, these scenario-ready capabilities show how Ozelle extends advanced morphology intelligence beyond routine CBC to address both everyday clinical care and high-risk public health needs.
At the foundation of Ozelle's system is AI-powered Complete Blood Morphology (CBM), which combines high-resolution imaging with real-time algorithmic analysis for deeper, actionable insights. Combined with a maintenance-free, easy-to-use device design, the system delivers long-term reliability, ideal for primary care clinics, chain laboratories, and decentralized testing sites.
Ozelle's technology is validated through 50,000+ global installations, generating 50 million+ cell images daily and over 100 billion real-world data points. Continuous algorithm refinement via an industry-exclusive quality control system ensures lab-grade performance that remains stable, scalable, and sustainable over time.
Related Links:
Ozelle







